Abbott | Satış Ve Yönetim Giderleri



Selling And Administration Expenses Değişiklik Tarih
Abbott USD 2.91B 21M 2024-12
Agilent USD 410M 16M 2025-01
AtriCure USD 72.18M 1.05M 2024-12
Baxter International USD 615M 16M 2024-12
Becton, Dickinson and Co. USD 1.32B 62M 2024-12
Bio-Rad Laboratories USD 199.7M 740K 2024-12
Boston Scientific USD 1.61B 50M 2024-12
Cooper Companies USD 387.9M 3.5M 2025-01
Danaher USD 2.02B 185M 2024-12
Dexcom USD 327.4M 21M 2024-12
Edwards Lifesciences USD 491.9M 70.5M 2024-12
Globus Medical USD 253.48M 12.74M 2024-12
Hologic USD 265M 15.8M 2024-12
Insulet USD 261M 26.9M 2024-12
Integra LifeSciences USD 169.62M 5.48M 2024-12
Intuitive Surgical USD 612.6M 102M 2024-12
J&J USD 6.45B 975M 2024-12
Masimo USD 223.4M 38.6M 2024-12
Medtronic USD 2.72B 34M 2025-01
Merit Medical Systems USD 102.57M 2.93M 2024-12
Pfizer USD 4.27B 1.06B 2024-12
Smith & Nephew USD 1.35B 12.8M 2024-12
Solventum Corp 784M 83M 2024-12
Stryker USD 2.03B 229M 2024-12
Tandem Diabetes Care USD 105.84M 6.2M 2024-12
Teleflex USD 254.55M 7.3M 2024-12
Terumo JPY 96.35B 3.76B 2024-12
Thermo Fisher Scientific USD 2.21B 114M 2024-12
Zimmer Biomet Holdings USD 724.7M 18.8M 2024-12



Abbott Satış Ve Yönetim Giderleri - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Mar 2025.